A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease
- Conditions
- Aortic Valve Disease
- First Posted Date
- 2010-09-03
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 105
- Registration Number
- NCT01194362
- Locations
- 🇺🇸
The Heart Hospital Baylor Plano, Plano, Texas, United States
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
Phase 1
Completed
- Conditions
- Malignant Melanoma Stage IVMalignant Melanoma Stage III
- Interventions
- Biological: IL15-DC Vaccine
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2016-12-22
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT01189383
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity Resp Insufficiency
Completed
- Conditions
- Respiratory Insufficiency
- Interventions
- Device: TOSCA 500 monitor
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT01188590
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts
Phase 2
- Conditions
- Liver Transplant
- Interventions
- Procedure: Inhaled Nitric Oxide (iNO)
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 2
- Registration Number
- NCT01172691
- Locations
- 🇺🇸
Baylor Univsersity Medical Center, Dallas, Texas, United States
Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2016-01-18
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 25
- Registration Number
- NCT01158105
- Locations
- 🇺🇸
Charles A. Cancer Center, Baylor University Medical Center, Dallas, Texas, United States
Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 102
- Registration Number
- NCT01083914
- Locations
- 🇺🇸
The Heart Hospital at Baylor Plano, Plano, Texas, United States
The Natural History of Mucolipidosis Type IV
- Conditions
- Mucolipidosis Type IV
- First Posted Date
- 2010-02-12
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 35
- Registration Number
- NCT01067742
- Locations
- 🇺🇸
Baylor Institute of Metabolic Disease, Dallas, Texas, United States
Fabry Screening Study
Completed
- Conditions
- Fabry Disease
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2018-02-13
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 2724
- Registration Number
- NCT01019629
- Locations
- 🇺🇸
Baylor Institute of Metabolic Disease, Dallas, Texas, United States
The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants
Not Applicable
- Conditions
- Central Line Bloodstream Infections
- Interventions
- Device: Silver Alginate
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 300
- Registration Number
- NCT00964093
- Locations
- 🇺🇸
Baylor University Medical Center - Women and Children's Services, Dallas, Texas, United States
Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease
Phase 2
Completed
- Conditions
- Adult Polyglucosan Body DiseaseGlycogen Brancher Enzyme DeficiencyGlycogen Storage Disease Type IV
- Interventions
- Other: Vegetable Oil
- First Posted Date
- 2009-07-28
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 23
- Registration Number
- NCT00947960
- Locations
- 🇫🇷
Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière, Paris, France